Entrada Therapeutics Share Price (NASDAQ: TRDA)
$5.62
Last updated on
Check the interactive Entrada Therapeutics Stock chart to analyse performance
Entrada Therapeutics stock performance
as on August 27, 2025 at 10:39 pm IST
- Today's Low:$5.48Today's High:$5.62
2.58%
Downside
Day's Volatility :2.58%
Upside
0.0%
- 52 Weeks Low:$4.9352 Weeks High:$21.79
12.28%
Downside
52 Weeks Volatility :77.37%
Upside
74.21%
Entrada Therapeutics Stock Returns
Entrada Therapeutics, Inc. Key Stats
Check Entrada Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Entrada Therapeutics Stock including INR - Dollar returns
The Entrada Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Entrada Therapeutics investment value today
Current value as on today
₹38,240
Returns
Returns from Entrada Therapeutics Stock
Dollar Returns*
₹4,587 (+4.59%)
Indian investors sentiment towards Entrada Therapeutics Stock
Global Institutional Holdings in Entrada Therapeutics, Inc.
Name
Holdings %
Baker Bros Advisors LP
12.79%
Mpm Asset Management, LLC
11.52%
5AM Venture Management, LLC
11.33%
T. Rowe Price Associates, Inc.
6.75%
BlackRock Inc
5.23%
Vanguard Group Inc
4.22%
Analyst Recommendation on Entrada Therapeutics Stock
Buy
90%Buy
10%Hold
0%Sell
Based on 10 Wall street analysts offering stock ratings for Entrada Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Entrada Therapeutics Share Price Target
What analysts predicted
Upside of 229.18%
Target:
$18.50
Current:
$5.62
Entrada Therapeutics share price target is $18.50, a slight Upside of 229.18% compared to current price of $5.62 as per analysts' prediction.
Entrada Therapeutics Stock Insights
Price Movement
In the last 3 months, TRDA stock has moved down by -26.9%TRDA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 127.3%TRDA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 175.2%Price to Sales
ForTRDA every $1 of sales, investors are willing to pay $2.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.
Entrada Therapeutics Technicals Summary
Sell
Neutral
Buy
Entrada Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Entrada Therapeutics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -9.63% | -53.16% | -66.29% | -52.09% | -76.49% |
 | 5.16% | -16.9% | -51.12% | -0.89% | -2.51% |
| 4.54% | 18.87% | 52.28% | 84.02% | 26.72% |
 | -16.02% | -19.22% | -19.42% | 37.43% | 43.36% |
 | 38.9% | 84.99% | 60.96% | 115.82% | 243.29% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 10.05 | NA | NA | -3.59 | -0.18 | -0.12 | NA | 10.68 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 27.64 | 27.64 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $214.1M | -76.49% | 10.05 | -92.3% |
| Buy | $62.5B | -2.51% | 14.86 | 31.37% |
| NA | $38.3B | 26.72% | NA | -3.89% |
| Buy | $99.7B | 43.36% | 27.64 | 31.86% |
| Buy | $58.2B | 243.29% | NA | -12.96% |
About Entrada Therapeutics, Inc.
Key Management of Entrada Therapeutics, Inc.
Important FAQs about investing in TRDA Stock from India :
What is Entrada Therapeutics share price today?
Entrada Therapeutics share price today is $5.62 as on at the close of the market. Entrada Therapeutics share today touched a day high of $5.62 and a low of $5.48.
What is the 52 week high and 52 week low for Entrada Therapeutics share?
Entrada Therapeutics share touched a 52 week high of $21.79 and a 52 week low of $4.93. Entrada Therapeutics stock price today i.e. is closed at $5.62, lower by 74.21% versus the 52 week high.
How to invest in Entrada Therapeutics Stock (TRDA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Entrada Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entrada Therapeutics Shares that will get you 0.2669 shares as per Entrada Therapeutics share price of $5.62 per share as on August 27, 2025 at 10:39 pm IST.
What is the minimum amount required to buy Entrada Therapeutics Stock (TRDA) from India?
Indian investors can start investing in Entrada Therapeutics (TRDA) shares with as little as ₹87.788 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.88 in Entrada Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 27, 2025).
Based on Entrada Therapeutics share’s latest price of $5.62 as on August 27, 2025 at 10:39 pm IST, you will get 1.7794 shares of Entrada Therapeutics. Learn more about
fractional shares .
What are the returns that Entrada Therapeutics has given to Indian investors in the last 5 years?
Entrada Therapeutics stock has given -76.49% share price returns and 18.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Grupo Televisa, S.a.b.$2.48
-0.4%
Kura Sushi Usa Inc-class A$79.62
+1.23%
Skillsoft Corp$16.12
+1.07%
Sunlands Online Education Group$9.17
-7.28%
Dennys$4.65
+3.33%
Xpel Inc$38.10
-0.37%
Gladstone Land Corporation$9.11
+0.55%
Stitch Fix, Inc. (class A Shares)$5.24
+2.95%
Immunocore Holdings Plc-adr$32.67
+0.25%